Expert Opinion on Drug Delivery

Papers
(The H4-Index of Expert Opinion on Drug Delivery is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery76
Metallic nanoparticles as drug delivery system for the treatment of cancer72
Microneedle arrays for the treatment of chronic wounds72
Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action67
Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities63
Release mechanisms and applications of drug delivery systems for extended-release55
Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update55
Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes?53
Advances in lyotropic liquid crystal systems for skin drug delivery52
Wound dressings as growth factor delivery platforms for chronic wound healing47
A review of recent advances in nanodiamond-mediated drug delivery in cancer46
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance45
Surface-modified polymeric nanoparticles for drug delivery to cancer cells44
Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung43
Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis42
Manipulative magnetic nanomedicine: the future of COVID-19 pandemic/endemic therapy40
Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy39
Nose-to-brain delivery of antipsychotics using nanotechnology: a review39
Emerging potential of niosomes in ocular delivery39
Electrospun nanofiber-based drug delivery platform: advances in diabetic foot ulcer management39
Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation38
Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells38
Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection38
Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies37
Clay nanoparticles as pharmaceutical carriers in drug delivery systems36
Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans36
Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer36
Orally administered self-emulsifying drug delivery system in disease management: advancement and patents36
Circumventing antimicrobial-resistance and preventing its development in novel, bacterial infection-control strategies36
Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research33
The perspectives of intra-articular therapy in the management of osteoarthritis33
Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer33
Advancing of titanium medical implants by surface engineering: recent progress and challenges32
Commercialization challenges for drug eluting contact lenses32
0.024358034133911